Metastatic Triple-Negative Breast Cancer (mTNBC) Market is driven...

added blog Other

2025-05-05 14:05:40 -

Metastatic Triple-Negative Breast Cancer (mTNBC) Market is driven by targeted therapies

Metastatic triple-negative breast cancer (mTNBC) is a highly aggressive subtype characterized by the absence of estrogen receptors, progesterone receptors, and HER2 expression. Representing roughly 15–20% of all breast cancers, mTNBC poses significant therapeutic challenges due to its heterogeneity, rapid progression, and limited response to hormone- or HER2-directed agents. Current...

0 Comments 0 Shares 163 Views 0 Reviews